EOLS Q3 2019 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M

Gross Profit

$9M71.8% margin

Operating Income

-$25M-190.9% margin

Net Income

-$27M-204.9% margin

EPS (Diluted)

$-0.98

QoQ Revenue Growth

+469.8%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$183M

Total Liabilities

$166M

Stockholders' Equity

$17M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$0	—
Gross Profit	$9M	$0	—
Operating Income	-$25M	-$11M	-118.8%
Net Income	-$27M	-$12M	-128.1%